Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 1000
Single User License Price INR 72520
Corporate User License Price USD 3000
Corporate User License Price INR 217560
Site License Price USD 2000
Site License Price INR 145040
Request a Quote

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals

Quote Request for License Type
License Type Price  
Single User License USD 1000
Site License USD 2000
Enterprise Wide License USD 3000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals


Quote Request for License Type
License Type Price  
Single User License USD 1000
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals



Executive Summary

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals

Summary

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals based on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the six months.

- Information on the top deals happened in the pharmaceutical industry.

- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.

- Find out the major deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the market

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

- Identify growth segments and opportunities in each region within the industry.

- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Pharmaceuticals & Healthcare, Global, Deal Summary 12

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2016 12

2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2016 14

2.2.1 Pfizer to Acquire Medivation in Tender Offer 14

2.2.2 Samsung Biologics Files Registration Statement for IPO for up to USD2.7 Billion 15

2.2.3 BioMarin Pharma Prices Public Offering of Shares for USD720 Million 16

2.2.4 Pfizer Acquires Bamboo Therapeutics 16

2.2.5 Sunovion Pharma to Acquire Cynapsus Therapeutics for Approximately USD624 Million 16

2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2016 18

2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2016 19

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20

3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2016 20

3.1.1 Top M&A Deals in August 2016 21

3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2016 - August 2016 22

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2016 23

3.2.1 Top Equity Offering Deals in August 2016 24

3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2016 - August 2016 25

3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2016 26

3.3.1 Top PE/VC Deals in August 2016 27

3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2016 28

3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2016 29

3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2016-August 2016 31

3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2016-August 2016 32

3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2016 33

3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2016 - August 2016 35

3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2016 36

3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2016 37

3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 38

3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2016 - August 2016 40

3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2016 - August 2016 41

3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 43

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2016 45

4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2016 45

4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2016 47

4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2016 - August 2016 49

4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2016 - August 2016 51

4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2016 - August 2016 52

4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2016 - August 2016 54

4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2016 55

4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2016 56

4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2016 56

5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 57

5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2016 57

5.1.1 Oncology - Deals of the Month 58

5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2016 60

5.2.1 Central Nervous System - Deals of the Month 61

5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2016 64

5.3.1 Infectious Diseases - Deals of the Month 65

5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2016 66

5.4.1 Cardiovascular - Deals of the Month 67

5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2016 68

5.5.1 Immunology - Deals of the Month 69

5.6 Pharmaceuticals & Healthcare, Global, Dermatology Deals, August 2016 71

5.6.1 Dermatology - Deal of the Month 72

5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, August 2016 74

5.7.1 Metabolic Disorders - Deal of the Month 75

6 Deal Summary by Geography 76

6.1 Pharmaceuticals & Healthcare, North America Deals, August 2016 76

6.1.1 North America - Deals of the Month 77

6.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2016 79

6.2.1 Europe - Deals of the Month 80

6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2016 83

6.3.1 Asia-Pacific - Deals of the Month 84

6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2016 86

6.4.1 Rest of the World - Deals of the Month 87

7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 89

7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2016 - August 2016 89

7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2016 - August 2016 91

8 Further Information 93

8.1 Methodology 93

8.2 About GlobalData 94

8.3 Disclosure information 94

8.4 Disclaimer 95

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

1.2 List of Figures

Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 12

Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2016 18

Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2016 19

Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 20

Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2016 - August 2016 22

Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 23

Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 25

Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 26

Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2016 - August 2016 28

Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2016 29

Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2016 30

Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 31

Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 33

Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 35

Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 36

Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 38

Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2016 - August 2016 40

Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2016 - August 2016 41

Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 43

Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 45

Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 47

Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 49

Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 51

Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2016 - August 2016 52

Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), March 2016 - August 2016 53

Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), August 2016 54

Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 57

Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 60

Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 64

Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 66

Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 68

Figure 32: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 71

Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 74

Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 76

Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 79

Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 83

Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 86

Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 89

Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 91

1.1 List of Tables

Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 13

Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2016 14

Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2016 19

Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 21

Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2016 21

Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2016 - August 2016 22

Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 24

Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2016 24

Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 25

Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 27

Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2016 27

Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2016 - August 2016 28

Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2016 30

Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 31

Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2016 - August 2016 32

Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 34

Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 35

Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 36

Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), August 2016 37

Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 39

Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2016 - August 2016 42

Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), March 2016 - August 2016 44

Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 46

Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 48

Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 50

Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), August 2016 51

Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2016 - August 2016 53

Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2016 55

Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2016 55

Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2016 56

Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2016 56

Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 58

Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 61

Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 65

Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 67

Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 69

Table 37: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 72

Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 75

Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 77

Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 80

Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 84

Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 87

Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 90

Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2016 - August 2016 92

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand